@pfizer's Dafydd Owen now talking in the #MEDI symposium #COVID19 Therapeutic Approaches at #ACSSpring2021
He's talking about small molecules that inhibit SARS-CoV-2's main protease
This is their IV clinical candidate
This is the new oral clinical candidate
A nicer version in @cenmag style
Owen said there were 210 people involved in advancing the clinical candidate.
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.
